Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study

Georgina V. Long, M.S. Carlino, Catriona M. McNeil, Antoni Ribas, Caroline Gaudy‐Marqueste, Jacob Schachter, Marta Nyakas, Damien Kee, Teresa M. Petrella, Arnold Blaustein, Michal Lotem, Ana Arance, Adil Daud, Omid Hamid, James Larkin, Yao Li, Rohit Kumar Singh, Richa Lal, Caroline Robert